search
Back to results

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

Primary Purpose

COVID-19, Influenza A, Influenza B

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
MGC Health COVID-19 & Flu A+B Home Multi Test
MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)
Sponsored by
Medical Group Care, LLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for COVID-19 focused on measuring COVID-19, Flu A, Flu B, Influenza

Eligibility Criteria

2 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: An Institutional Review Board (IRB) approved informed consent / assent, if applicable, is signed and dated prior to any study related activities. Male and female subjects 2 years of age and older. Subject is willing to provide a self-collected nasal swab sample. (If the subject is under the age of 14, an adult lay user will collect the sample.) Subject agrees to complete all aspects of the study. Exclusion Criteria: Subject has a visual impairment that cannot be restored with glasses or contact lenses. Subject has prior medical or laboratory training. Subject uses home diagnostics, e.g., glucose meters, HIV tests. Subject has prior knowledge of their current COVID-19 or flu infection status.

Sites / Locations

  • L&A Morales Healthcare

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Individuals - ages 14 and older

Individuals - ages 2 to 13

Arm Description

This test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older.

This kit is intended for non-prescription home use with self-collected direct anterior nares swab samples. If the subject is under the age of 14, an adult lay-user will collect the sample.

Outcomes

Primary Outcome Measures

Usability of Quick Reference Instructions (QRI)
Assess the usability of the Quick Reference Instructions (QRI) based upon observer evaluation.
Usability of Test Kit
Assess the usability of the kit for home use based upon subject evaluation.

Secondary Outcome Measures

Full Information

First Posted
February 15, 2023
Last Updated
March 21, 2023
Sponsor
Medical Group Care, LLC
Collaborators
CSSi Life Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05732610
Brief Title
MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
Official Title
MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
February 14, 2023 (Actual)
Primary Completion Date
February 28, 2023 (Actual)
Study Completion Date
March 2, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical Group Care, LLC
Collaborators
CSSi Life Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the usability of the MGC Health COVID-19 & Flu A+B Home Multi Test in home use.
Detailed Description
The MGC Health COVID-19 & Flu A+B Home Multi Test is a lateral flow immunochromatographic antibody assay intended for the simultaneous qualitative detection and differentiation of the nucleocapsid antigen from SARS-CoV-2, influenza A and/or influenza B directly from anterior nasal swab specimens obtained from individuals, who are suspected of respiratory viral infection within five (5) days of symptom onset. This test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older or adult lay user collected anterior nares swab samples from individuals aged 2 to 13 years. The objective of the study is to determine the usability of the MGC Health COVID-19 & Flu A+B Home Multi Test in a simulated home use environment. This is an open label study to evaluate the usability of the MGC Health COVID-19 & Flu A+B Home Multi Test using information from the Quick Reference Instructions (QRI).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19, Influenza A, Influenza B
Keywords
COVID-19, Flu A, Flu B, Influenza

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is an open label study to evaluate the usability of the MGC Health COVID-19 & Flu A+B Home Multi Test using information from the Quick Reference Instructions (QRI).
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Individuals - ages 14 and older
Arm Type
Experimental
Arm Description
This test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older.
Arm Title
Individuals - ages 2 to 13
Arm Type
Experimental
Arm Description
This kit is intended for non-prescription home use with self-collected direct anterior nares swab samples. If the subject is under the age of 14, an adult lay-user will collect the sample.
Intervention Type
Diagnostic Test
Intervention Name(s)
MGC Health COVID-19 & Flu A+B Home Multi Test
Intervention Description
self-collected direct anterior nares swab samples
Intervention Type
Diagnostic Test
Intervention Name(s)
MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)
Intervention Description
adult lay user collected anterior nares swab sample
Primary Outcome Measure Information:
Title
Usability of Quick Reference Instructions (QRI)
Description
Assess the usability of the Quick Reference Instructions (QRI) based upon observer evaluation.
Time Frame
One Month
Title
Usability of Test Kit
Description
Assess the usability of the kit for home use based upon subject evaluation.
Time Frame
One Month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: An Institutional Review Board (IRB) approved informed consent / assent, if applicable, is signed and dated prior to any study related activities. Male and female subjects 2 years of age and older. Subject is willing to provide a self-collected nasal swab sample. (If the subject is under the age of 14, an adult lay user will collect the sample.) Subject agrees to complete all aspects of the study. Exclusion Criteria: Subject has a visual impairment that cannot be restored with glasses or contact lenses. Subject has prior medical or laboratory training. Subject uses home diagnostics, e.g., glucose meters, HIV tests. Subject has prior knowledge of their current COVID-19 or flu infection status.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janice Cattano, RN, MSN
Organizational Affiliation
CSSi LifeSciences
Official's Role
Study Director
Facility Information:
Facility Name
L&A Morales Healthcare
City
Miami
State/Province
Florida
ZIP/Postal Code
33142
Country
United States

12. IPD Sharing Statement

Learn more about this trial

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

We'll reach out to this number within 24 hrs